Massachusetts Regulators Address Soaring Insurance Costs
State officials are weighing new strategies to curb premium hikes driven by expensive specialty medications.
Updated on Oct. 20, 2026 in Healthcare
Live Poll
Is health insurance becoming less affordable in your area due to rising specialty drug costs?
The Massachusetts Division of Insurance recently held a public listening session to address rising premium costs across the state. Regulators are examining how specialty drugs and declining enrollment contribute to a 10.4% premium increase set for 2027.
Why it matters
Insurers report that soaring pharmaceutical costs and the emergence of ultra-expensive gene therapies are destabilizing the market. Governor Maura Healey has directed regulators to find new ways to stabilize premiums for residents and employers.
Massachusetts approved a 10.4% average premium increase for the 2027 merged market, while Mass General Brigham Health Plan reported 17 individual claims exceeding $1 million last year.
The players
Maura Healey
She is the Governor of Massachusetts who has instructed the state's Division of Insurance to evaluate cost-reduction strategies.
Massachusetts Division of Insurance
This state agency regulates insurance markets and is currently reviewing strategies to stabilize coverage costs.
Mass General Brigham Health Plan
This healthcare organization provides insurance services and reported a high volume of million-dollar claims.
The details
Massachusetts is struggling with a high volume of specialty drug costs and 59 distinct state-mandated insurance coverage requirements. As fully insured marketplace enrollment declines, many small businesses are shifting to self-funded models that utilize stop-loss insurance to mitigate catastrophic financial risks.
Timeline
Last year: Mass General Brigham Health Plan logged 17 claims surpassing $1 million.
Monday, October 19, 2026: The Division of Insurance hosted a public listening session.
2027: A 10.4% average premium increase takes effect for the merged market.
Market Landscape
The current insurance crisis in Massachusetts is complicated by the state's 59 mandates for insurance coverage. This regulatory environment creates unique challenges as insurers grapple with the rising costs of emerging cell and gene therapies.
Residents and small business owners in Massachusetts face a 10.4% increase in insurance premiums starting in 2027. This shift may force more local employers to transition away from fully insured plans toward self-funded models to manage costs.
The takeaway
The rapid rise in costs for specialty gene and cell therapies is creating significant strain on state-level insurance markets. Policyholders should review their current plans and expected premium adjustments to prepare for the upcoming 2027 rate hikes.
Further reading
For more context on how state policies impact the local medical market, see Massachusetts Healthcare.
Source note: This article includes information reported by 22 News WWLP.
Live Poll
Is health insurance becoming less affordable in your area due to rising specialty drug costs?
